Endocrine markers of severity and prognosis in critical illness

Critical Care Clinics

Volumn 22, Issue 1, 2006, Pages 161-179

  Nylén, Eric S ^a,b   Seam, Nitin ^c   Khosla, Rahul ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCITONIN; COMPLEMENT; CYTOKINE; ENDOTHELIN 1; ENZYME INHIBITOR; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; HYDROCORTISONE; INSULIN; LIPID; MIGRATION INHIBITION FACTOR; N(G),N(G) DIMETHYLARGININE; NATRIURETIC FACTOR; NITRIC OXIDE; PEXELIZUMAB; PRASTERONE SULFATE; PROCALCITONIN; PROTEIN; THROMBOCYTE ACTIVATING FACTOR; THYROID HORMONE; TP 10; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL 1; UNCLASSIFIED DRUG;

BLOOD CLOTTING; CLINICAL TRIAL; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPOCHOLESTEROLEMIA; INJURY; INTENSIVE CARE UNIT; METABOLISM; OBESITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPTIC SHOCK;

BIOLOGICAL MARKERS; CRITICAL ILLNESS; HUMANS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STRESS;

EID: 29844446331     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2005.08.002     Document Type: Review

References (155)

1. rd edition 2001 Lippincott, Williams Wilkins Philadelphia 2077 2087
2. S.R. Bornstein, and G.P. Chrousos The hypothalamic-pituitary-adrenal axis in stress and critical illness K.L. Becker Principles and practice of endocrinology and ott, Williams Wilkins Philadelphia 2087 2094
3. A.H. Hamrahian, O.S. Tawakalitu, and B.M. Arafah Measurements of serum free cortisol in critically ill patients N Engl J Med 350 2004 1629 1638
4. L.F. Span, A.R. Hermus, and A.K. Bartelink Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients Intensive Care Med 18 1992 93 96
5. P.D. Woolf Hormonal responses to trauma Crit Care Med 20 1992 216 226
6. S. Sam, T.C. Corbridge, and B. Mokhlesi Cortisol levels and mortality in severe sepsis Clin Endocrinol (Oxf) 60 2004 29 35
7. W.E. Finlay, and J.I. McKee Serum cortisol levels in severely stressed patients Lancet 1 1982 1414 1415
8. P. Marik, and G. Zaloga Adrenal insufficiency in the critically ill: a new look at an old problem Chest 122 2002 1784 1796
9. P.M. Rothwell, and P.G. Lawler Prediction of outcome in intensive care patients using endocrine parameters Crit Care Med 23 1995 78 83
10. D. Annanne, V. Sebille, and G. Troche A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin JAMA 283 2000 1038 1045
11. A. Beishuizen, L.G. Thijs, and I. Vermes Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care 6 2002 434 438
12. Wiebke A., Hammer F., Sanning P., et al. No evidence for DHEA deficiency in severe sepsis-a stress paradigm revisited. Abstract P3-430; p. 648
13. L. Friberg, S. Werner, G. Eggertsen, and S. Ahnve Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med 162 2002 1388 1394
14. E.M. Kaptein, W.J. Robinson, and D.A. Grieb Peripheral serum thyroxine, triiodothyronine and reverse triiodonine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis J Clin Invest 69 1982 526 535
15. R. Docter, E.P. Krenning, and M. de Jong The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism Clin Endocrinol (Oxf) 39 1993 499 518
16. J. Simpson, F.L.R. Williams, and C. Delahunty Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness J Clin Endocrinol Metab 90 2005 1271 1279
17. M.F. Slag, J.E. Morley, and M.K. Elson Hypothyroxinemia in critically ill patients as a predictor of high mortality JAMA 245 1981 43 45
18. R.P. Peeters, P.J. Wouters, and H. von Toor Serum rT3 and T3/rT3 are prognostic markers in critically ill patients and are associated with post-mortem tissue deiodinase activities J Clin Endocrinol Metab 90 8 2005 4559 4565
19. S. Sumita, Y. Ujike, and A. Namiki Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness Crit Care Med 22 1994 1603 1609
20. E.M. Kaptein, J.M. Weiner, and W.J. Robinson Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses Clin Endocrinol (Oxf) 16 1982 565 574
21. R. Witthaut Science review: natriuretic peptides in critical illness Crit Care 8 2004 342 349
22. A.K. Kiemer, T. Hartung, and A.M. Vollmar cGMP-mediated inhibition of TNF-alpha by the atrial natriuretic peptide in murine macrophages J Immunol 165 2000 175 181
23. C.J. Wiedemann, M. Niedermuhlbichler, and H. Braunsteiner Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro J Clin Invest 89 1992 1580 1586
24. R. Witthaut, C. Busch, and P. Fraunberger Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction Intensive Care Med 29 2003 1696 1702
25. B. Mazul-Sunko, N. Zarkovic, and N. Vrkic Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients J Endocrinol Invest 24 7 2001 RC22 RC24
26. N.G. Morgenthaler, J. Struck, and M. Christ-Crain Pro-atrial natriuretic peptide is a prognostic marker in sepsis similar to the APACHE II score:an observational study Crit Care 169 2005 37 45
27. J. Charpentier, C.E. Luyt, and Y. Fulla Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis Crit Care Med 32 2004 660 665
28. A. Roch, J. Allardet-Servent, and P. Michelet NH2 terminal pro-brain natriuretic peptide plasma levels as an early marker of prognosis and cardiac dysfunction in septic shock patients Crit Care Med 33 2005 1001 1007
29. E. Berendes, H. Van Aken, and C. Raufhake Differential secretion of atrial and brain natriuretic peptide in critically ill patients Anesth Analg 93 2001 676 682
30. B.A. Mizok Alterations in fuel metabolism in critical illness: hyperglycemia Best Practice & Res Clin Endocrinol Metab 15 2001 533 551
31. K. Malmberg Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study Endocr Pract 10 2004 S13 S16
32. A.M. Norhammar, L. Ryden, and K. Malmberg Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients Diabetes Care 33 1999 1827 1831
33. J. Bolk, T. van der Ploeg, and J.H. Cornel Impaired glucose metabolism predicts mortality after a myocardial infarction J Cardiol 79 2001 207 214
34. S.E. Capes, D. Hunt, and K. Malmberg Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 2000 773 778
35. T. Moulin, L. Tatu, and T. Crepin-Leblond The Besancon stroke registry: an acute stroke registry of 2500 consecutive patients Eur Neurol 38 1997 10 20
36. C.J. Weir, G.D. Murray, and A.G. Dyker Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study BMJ 314 1997 1303 1306
37. T.A. Kent, V.M. Soukup, and R.H. Fabian Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse Stroke 32 2001 2318 2327
38. T.A. Baird, M.W. Parsons, and T. Phanh Persistent post-stroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome Stroke 34 2003 2208 2214
39. S.E. Capes, D. Hunt, and K. Malmberg Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 2000 773 778
40. G. Van den Berghe, R. Bouillon, and P. Lauwers Intensive insulin therapy in critically ill patients N Engl J Med 345 2001 1359 1367
41. G. Van den Berghe, P.J. Wouters, and R. Bouillon Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control Crit Care Med 31 2003 359 366
42. S.J. Finney, C. Zekveld, and A. Elia Glucose control and mortality in critically ill patients JAMA 290 2003 2041 2047
43. J.S. Krinsley Effect of an intensive glucose management protocol on the mortality of critically ill patients Mayo Clin Proc 79 2004 977 988
44. G.V. Bochicchio, J. Sung, and M. Joshi Persistent hyperglycemia is predictive of outcome in critically ill trauma patients J Trauma 58 2005 921 924
45. J.J. Ligtenberg, S. Meijering, and M. Vogelzang Relationship of baseline glucose and mortality during medical critical illness? Chest 127 2005 2283
46. C. Christiansen, P. Toft, and H.S. Jorgensen Hyperglycemia and mortality in critically ill patients Intensive Care Med 30 2004 1685 1688
47. D. Gui, P.L. Spada, and A. De Gaetano Hypocholesterolemia and the risk of death in the critically ill surgical patient Intensive Care Med 22 1996 790 794
48. B.R. Gordon, T.S. Parker, and D.M. Levine Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients Crit Care Med 29 2001 1563 1568
49. D.A. Bonville, T.S. Parker, and D.M. Levine The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome Surg Infect (Larchmt) 5 2004 39 49
50. L. Lind, and H. Lithell Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival Clin Intensive Care 5 1994 100 105
51. D. Messottten, J.V. Swinnen, and F.V. Vanderhoydonc Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy J Clin Endocrinol Metab 89 2004 1219 1226
52. C. Goulenok, M. Monchi, and J.D. Chiche Influence of overweight on ICU mortality: a prospective study Chest 125 2004 1441 1445
53. A. Blanco Quiros, J. Casado Flores, and M. Nieto Moro Meningococcal sepsis in pediatrics. Parameters associated with poor outcome An Pediatr (Barc) 61 2004 305 313
54. S.L. Barriere, and S.F. Lowry An overview of mortality risk prediction in sepsis Crit Care Med 23 1995 376 393
55. F. Gebhard, H. Pfetsch, and G. Steinbach Is interleukin-6 and early marker of injury severity following major trauma in humans? Arch Surg 135 2000 291 295
56. E.A. Panacek, and M. Kaul IL-6 as a marker of excessive TNF-alpha activity in sepsis Sepsis 3 1999 65 73
57. H.E. Wasmuth, D. Kunz, and J. Graf Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha Crit Care Med 32 2004 1109 1114
58. D. Bouros, M.G. Alexandrakis, and K.M. Antoniou The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for acute respiratory distress syndrome BMC Pulm Med 4 2004 6
59. C.A. Gogos, E. Drosou, and H.P. Bassaris Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options J Infect Dis 181 2000 176 180
60. M.R. Pinsky, J.L. Vincent, and J. Deviere Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality Chest 103 1993 565 575
61. C.E. Hack, E.R. De Groot, and R.J. Felt-Bersma Increased plasma levels of interleukin-6 in sepsis Blood 74 1989 1704 1710
62. E. Watanabe, H. Hirasawa, and S. Oda Extremely high interleukin-6 levels and outcome in the critically ill are associated with tumor necrosis factor and interleukin-1 gene related polymorphism Crit Care Med 33 2005 89 97
63. E.A. Panacek, J.C. Marshall, and T.E. Albertson Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 Crit Care Med 32 2004 2173 2182
64. A. Oberholzer, S.M. Souza, and S.K. Tschoeke Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis Shock 23 2005 488 493
65. V. Pettila, M. Hynnien, and O. Takkunen Predictive value procalcitonin and interleukin-6 in critically ill patients with suspected sepsis Intensive Care Med 28 2002 1220 1225
66. L.G. Thijs, and C.E. Hack Time course of cytokine levels in sepsis Intensive Care Med 521 1999 S258 S263
67. R. Raghupathy, U.C. Chaturvedi, and H. Al-Sayer Elevated levels of IL-8 in dengue hemorrhagic fever J Med Virol 56 1998 280 285
68. C. Marty, B. Misset, and F. Tamion Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin Crit Care Med 22 1994 673 679
69. P.E. Parsons, M.D. Eisner, and B.T. Thompson Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury Crit Care Med 33 2005 1 6
70. P. Mentula, M.L. Kylanpaa, and E. Kemppainen Early prediction of organ failure by combined markers in patients with acute pancreatitis Br J Surg 92 2005 68 75
71. M. Hynninen, V. Pettila, and O. Takkunen Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis Shock 20 2003 1 4
72. K. Fuse, M. Kodama, and Y. Okura Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis Eur J Heart Fail 7 2005 109 112
73. M. Nishii, T. Inomata, and H. Takehana Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis J Am Coll Cardiol 44 2004 1292 1297
74. S. Ikuta, S. Ono, and M. Kinoshita Interleukin-18 concentration in the peritoneal fluid correlates with the severity of peritonitis Am J Surg 185 2003 550 555
75. A. Sablotzki, I. Friedrich, and J. Muhling The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions Perfusion 17 2002 103 109
76. R.J. Feezor, C. Oberholzer, and H.V. Baker Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria Infect Immun 71 2003 5803 5813
77. M. Suleiman, D. Aronson, and S.A. Reisner Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction Am J Med 115 2003 695 701
78. H. Bonig, D.T. Schneider, and I. Sprock Sepsis and multi-organ failure: predictors of poor outcome after hematopoietic stem cell transplantation in children Bone Marrow Transplant 26 2000 S32 S34
79. P.M. Ridker, M. Cushman, and M.J. Stampfer Plasma concentrations of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 1998 425 428
80. J.C. Pinilla, P. Hayes, and W. Laverty The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction Surgery 124 1998 799 805
81. N.J. Cano, C. Pichard, and H. Roth C-reactive protein and body mass index predict outcome in end-stage respiratory failure Chest 126 2004 540 546
82. S.M. Lobo, F.R. Lobo, and D.P. Bota C-reactive protein levels correlate with mortality and organ failure in critically ill patients Chest 123 2003 2043 2049
83. R.W. Chesney, D.M. McCarron, and J.G. Haddad Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome J Lab Clin Med 101 1983 576 585
84. K.L. Becker, E.S. Nylen, and J.C. White Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors J Clin Endocrinol Metab 89 2004 1512 1525
85. R.H. Snider Jr, E.S. Nylen, and K.L. Becker Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization J Investig Med 45 1997 552 560
86. E.S. Nylen, R.H. Snider Jr, and K.A. Thompson Pneumonitis-associated hyperprocalcitoninemia Am J Med Sci 312 1996 12 18
87. G.R. Stryjewski, E.S. Nylen, and M.J. Bell Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children Pediatr Crit Care Med 6 2 2005 129 135
88. K.T. Whang, P.M. Steinwald, and J.C. White Serum calcitonin precursors in sepsis and systemic inflammation J Clin Endocrinol Metab 83 1998 3296 3301
89. G.P. Castelli, C. Pognani, and M. Meisner Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction Crit Care 8 2004 R234 R242
90. C. Wunder, O. Eichelbronner, and N. Roewer Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II Inflamm Res 53 2004 158 163
91. D.C. Van der Kaay, E.D. De Kleijn, and Y.B. De Rijke Procalcitonin as a prognostic marker in meningococcal disease Intensive Care Med 28 2002 1606 1612
92. B. Muller, K.L. Becker, and H. Schachinger Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit Crit Care Med 28 2000 977 983
93. C. Clec'h, F. Ferriere, and P. Karoubi Diagnostic and prognostic value of procalcitonin in patients with septic shock Crit Care Med 32 2004 1166 1169
94. R. Claeys, S. Vinken, and H. Spapen Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates Crit Care Med 30 2002 757 762
95. H.G. Fritz, H. Brandes, and D.L. Bredle Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery Acta Anaesthesiol Scand 47 2003 1276 1283
96. V. Maxime, C. Fitting, and D. Annane Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock Infect Dis 191 2005 138 144
97. J. Bernhagen, T. Calandra, and R.A. Mitchell MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Nature 365 1993 756 759
98. T. Calandra, B. Echtenacher, and D.L. Roy Protection from septic shock by neutralization of macrophage migration inhibitory factor Nat Med 6 2000 164 170
99. A. Beishuizen, L.G. Thijs, and C. Haanen Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness J Clin Endocrinol Metab 86 2001 2811 2816
100. F.A. Bozza, R.N. Gomes, and A.M. Jappiassu Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis Shock 22 2004 309 313
101. H.T. de Mendonca-Filho, R.V. Gomes, and L.A. de Almeida Campos Circulating levels of macrophage migration inhibitory factor are associated with mild pulmonary dysfunction after cardiopulmonary bypass Shock 22 2004 533 537
102. H. Wang, H. Yang, and K.J. Tracey Extracellular role of HMGB1 in inflammation and sepsis J Intern Med 255 2004 320 331
103. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
104. J. Sunden-Cullberg, A. Norrby-Teglund, and A. Rouhiainen Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock Crit Care Med 33 2005 564 573
105. D. Hosford, M. Paubert-Braquet, and P. Braquet Platelet-activating factor and cytokine interactions in shock Resuscitation 18 1989 207 218
106. R.M. Graham, M.E. Strahan, and K.W. Norman Platelet and plasma platelet-activating factor in sepsis and myocardial infarction J Lipid Mediat Cell Signal 9 1994 167 182
107. M. Akisu, N. Kultursay, and I. Coker Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: is it an additional marker of perinatal asphyxia? Acta Paediatr Jpn 40 1998 427 431
108. A. Adunsky, M. Hershkowitz, and E. Atar Infarct volume, neurological severity and PAF binding to platelets of patients with acute cerebral ischemic stroke Neurol Res 21 1999 645 648
109. V.L. Serebruany, P.A. Gurbel, and S.R. Murugesan Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction Cardiology 90 1998 127 130
110. A. Bouchon, J. Dietrich, and M. Colonna Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes J Immunol 164 2000 4991 4995
111. M. Colonna, and F. Facchetti TREM-1 (triggering receptor expressed on myeloid cells-1). A new player in acute inflammatory responses J Infect Dis 187 2003 S397 S401
112. S. Gibot, M.N. Kolopp-Sarda, and M.C. Béné Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis Ann Intern Med 141 2004 9 15
113. S. Gibot, A. Cravoisy, and B. Levy Rapid detection of the soluble form of triggering receptor expressed on myeloid cells-1 (TREM-1) in the diagnosis of pneumonia N Engl J Med 350 2004 451 458
114. S. Gibot, and A. Cravoisy Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis Crit Care Med 33 2005 792 796
115. Z. Argaman, V.R. Young, and N. Noviski Arginine and nitric oxide metabolism in critically ill septic pediatric patients Crit Care Med 31 2003 591 597
116. A.H. Alzeer, A. Al-Arifi, and A.S. Warsy Nitric oxide production is enhanced in patients with heat stroke Intensive Care Med 25 1999 58 62
117. J.T. van Dissel, P.H. Groeneveld, and B. Maes Nitric oxide: a predictor of morbidity in postoperative patients? Lancet 343 1994 1579 1580
118. R.J. Nijveldt, T. Teerlink, and B. Van Der Hoven Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality Clin Nutr 22 2003 23 30
119. M.P. Siroen, P.A. van Leeuwen, and R.J. Nijveldt Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33 2005 504 510
120. J.S. Brauner, L.E. Rohde, and N. Clausell Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock Intensive Care Med 26 2000 305 313
121. J.F. Pittet, D.R. Morel, and A. Hemsen Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis Ann Surg 213 1991 261 264
122. J. Figueras-Aloy, L. Gomez-Lopez, and J.M. Rodriguez-Miguelez Plasma endothelin-1 manifestations of neonatal sepsis J Perinat Med 32 2004 522 526
123. A. Bengtsson Cascade system activation in shock Acta Anaesthes Scand 98 1993 S7 S10
124. H. Redl, G. Schlag, and S. Bahrami Experimental and clinical evidence of leukocyte activation in trauma and sepsis Prog Clin Biol Res 388 1994 221 245
125. M. Heideman, B. Norder-Hansson, and A. Bengtson Terminal complement complexes and anaphylatoxins in septic and ischemic patients Arch Surg 123 1988 188 192
126. J. Kildsgaard, T.J. Hollmann, and K.W. Matthews Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock J Immunol 165 2000 5406 5409
127. J.H. Stevens, P. O'Hanley, and J.M. Shapiro Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates J Clin Invest 77 1986 1812 1816
128. H.L. Lazar, Y. Bao, and J. Gaudiani Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass Circulation 100 1999 1438 1442
129. A.J. Fleisig, and E.D. Verrier Pexelizumab-a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass Expert Opin Biol Ther 5 2005 833 839
130. J.A. Lorente, L.J. Garcia-Frade, L. Landin, R. de Pablo, C. Torrado, and E. Renes Time course of hemostatic abnormalities in sepsis and its relation to outcome Chest 103 1993 1536 1542
131. M.L. McManus, and K.B. Churchwell Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura Crit Care Med 21 1993 706 711
132. G.T. Kinasewitz, S.B. Yan, and B. Basson Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism Crit Care 8 2004 R82 R90
133. C.T. Esmon The PC pathway Chest 124 2003 26S 32S
134. R.M. Mesters, J. Helterbrand, and B.G. Utterback Prognostic value of PC concentrations in neutropenic patients at high risk of severe septic complications Crit Care Med 28 2000 2209 2216
135. B.W. Grinnell, and D. Joyce Recombinant human aPC. A system modulator of vascular function for treatment of severe sepsis Crit Care Med 29 7 2001 S53 S61
136. R.M. Mesters, J. Helterbrand, and B.G. Utterback Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications Crit Care Med 28 2000 2209 2216
137. S.B. Yan, J.D. Helterbrand, and D.L. Hartman Low levels of protein C are associated with poor outcome in severe sepsis Chest 120 2001 915 922
138. M.A. Matthay, and L.B. Ware Plasma protein C levels in patients with acute lung injury: prognostic significance Crit Care Med 32 2004 S229 S232
139. M.H. Kollef, P.R. Eisenberg, and W. Shannon A rapid assay for detection of circulating D-dimer is associated with clinical outcomes among critically ill patients Crit Care Med 26 1998 1054 1060
140. T. Iba, A. Kidokoro, and M. Fukunaga Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers Shock 23 2005 25 29
141. J.M. Querol-Ribelles, and J.M. Tenias Plasma d-Dimer levels correlate with outcomes in patients with community acquired pneumonia Chest 126 2004 1087 1092
142. J.F. Dhainaut, A.F. Shorr, and W.L. Macias Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure Crit Care Med 33 2005 341 348
143. J. Boldt, M. Wollbruck, and D. Kuhn Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? Chest 107 1995 787 792
144. C.J. Cummings, C.N. Sessler, and L.D. Beall Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction Am J Respir Crit Care Med 156 1997 431 437
145. S. Ueda, K. Nishio, and N. Minamino Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome Am J Respir Crit Care Med 160 1999 132 136
146. E.D. Papathanassoglou, J.A. Moynihan, and D.L. Vermillion Soluble fat levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients Shock 14 2000 107 112
147. E. Berendes, P. Cullen, and H. Van Aken Endogenous glycosides in critically ill patients Crit Care Med 31 2003 1331 1337
148. F. Kimura, H. Itoh, and S. Ambiru Circulating heat-shock protein 70 is associated with postoperative infection and organ dysfunction after liver resection Am J Surg 187 2004 777 784
149. D. Mesotten, P.J. Delhanty, and F. Vanderhoydonc Regulation of insulin-like growth factor binding protein-1 during protracted critical illness J Clin Endocrinol Metab 87 2002 5516 5523
150. V. Mishra, M. Baines, and R. Wenstone Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients Ann Clin Biochem 42 2005 269 276
151. F. Arnalich, J. Lopez, and R. Codoceo Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock J Infect Dis 180 1999 908 911
152. P. Gosling, S. Brudney, and L. McGrath Mortality prediction at admission to intensive care: a comparison of microalbuminuria with acute physiology scores after 24 hours Crit Care Med 31 2003 98 103
153. S.G. Zakynthinos, S. Papanikolaou, and T. Theodoridis Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients Crit Care Med 32 2004 1004 1010
154. R.S. Wright, B.A. Williams, and H. Cramner Elevations of cardiac troponin I are associated with increased short term mortality in noncardiac critically ill emergency department patients Am J Cardiol 90 6 2002 634 636
155. S. Kayal, J.P. Jais, and N. Aguini Elevated circulating E-selectin intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection Am J Respir Crit Care Med 157 1998 776 784